Malaysia’s CCM Duopharma Biotech Bhd has picked up a 5.8 per cent stake in Korean SCM Lifescience while auto parts maker MeGroup is looking to raise S$2.4 million ($1.7 million) via its IPO on the Catalist board.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
